Tokyo, Aug. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058788) titled 'The effect of respiratory viral infection on exacerbation of bronchiectasis: a prospective cohort study' on Aug. 14.
Study Type:
Observational
Primary Sponsor:
Institute - Kyorin University Hospital
Condition:
Condition - Bronchiectasis and respiratory viral infections
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this prospective cohort study of patients with bronchiectasis is to clarify the detection status of respiratory viruses during stable and exacerbation periods and their impact on clinical outcomes.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with bronchiectasis who are 18 years of age or older, have had no exacerbations in the past 4 weeks, and have provided informed consent to participate in this study are eligible for inclusion. The diagnosis of bronchiectasis is based on chest HRCT findings of bronchiectasis and the presence of two of the following clinical symptoms: cough, sputum production, or a history of exacerbations.
Key exclusion criteria - Patients with cystic fibrosis, active tuberculosis, AIDS, those currently taking immunosuppressive drugs, those currently receiving systemic steroid therapy (equivalent to 20 mg/day or more of prednisolone on a daily basis), malignant tumors, or pulmonary fibrosis (traction bronchiectasis) are excluded.
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 13 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067219
Disclaimer: Curated by HT Syndication.
